← Back to Search

Oxytocin Analog

Merotocin for Premature Birth (MERMAID Trial)

Phase 2
Waitlist Available
Research Sponsored by Ferring Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Delivered at the hospital system associated with the trial center
Delivered preterm singleton gestational age 24 weeks + 0 days to 34 weeks + 2 days
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from screening (0-144 hours of delivery) up to day 18
Awards & highlights

MERMAID Trial Summary

This trial looks at whether a drug can help women with preterm babies and low milk production to make more milk.

Eligible Conditions
  • Premature Birth
  • Low Milk Supply

MERMAID Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

MERMAID Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from screening (0-144 hours of delivery) up to day 18
This trial's timeline: 3 weeks for screening, Varies for treatment, and from screening (0-144 hours of delivery) up to day 18 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Volume of Mother's Own Milk (MoM)
Secondary outcome measures
Change in Infant Body Weight
Changes in Routine Safety Laboratory Parameters in Maternal Participants
Frequency of AEs in Infants
+12 more

MERMAID Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Merotocin (a selective oxytocin-receptor agonist)Experimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Ferring PharmaceuticalsLead Sponsor
313 Previous Clinical Trials
440,854 Total Patients Enrolled
1 Trials studying Premature Birth
163 Patients Enrolled for Premature Birth
Global Clinical ComplianceStudy DirectorFerring Pharmaceuticals
62 Previous Clinical Trials
357,391 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

For this research, are only adults above a certain age being asked to participate?

"Eligible patients for this study must be 18 years old or older, but younger than 44."

Answered by AI

How many total participants are allowed in this clinical trial?

"The trial, which is being conducted by Ferring Pharmaceuticals, needs to recruit 100 eligible patients from various locations including Houston, Texas and Charleston, South carolina."

Answered by AI

Are there any unfilled positions for participants in this experiment?

"Yes, the trial is still recruiting patients. Originally posted on May 28th, 2021 and edited as recently as November 10th, 2022, this study has 100 enrollees with 19 different sites."

Answered by AI

Have other research groups conducted similar investigations before?

"Merotocin has been under scientific scrutiny since 2021 when the first clinical trial, sponsored by Ferring Pharmaceuticals, was completed. A Phase 2 study involving 100 patients allowed Merotocin to skip to drug approval stage. As of now, only one active trial is being conducted and funded by Ferring Pharmaceuticals."

Answered by AI

How many locations are currently conducting this trial?

"Yale School of Medicine in Houston, Cincinnati Children's Hospital Medical Center in Charleston, and Wake Medical Center in Cincinnati are three of the nineteen available locations for this clinical trial."

Answered by AI

Are there any recorded dangers of Merotocin?

"While there is some evidence of Merotocin's safety, it has not been proven effective yet and thus received a score of 2."

Answered by AI

Has Merotocin been used in previous research studies?

"Merotocin was first studied in 2021 at the Ferring Investigational Site. Including that original study, there have been a total of 18290 completed clinical trials as of now. Additionally, there is 1 actively recruiting trial presently, with a number of locations throughout Houston, Texas."

Answered by AI

Who would be an ideal candidate to help with this medical research?

"This trial is accepting 100 people with inadequate milk production aged 18 and 44. Most importantly, applicants should meet the following criteria: Delivered at the hospital system associated with the trial center, Delivered preterm singleton gestational age 24 weeks + 0 days to 34 weeks + 2 days, Willing to express milk at least 5 times every 24 hours during the observation period and 6 to 8 times every 24 hours during the treatment and post-treatment follow up, Produced < 200 mL milk in 24 hours prior to randomization, Delivered 96 to 192 (+4) hours prior to randomization."

Answered by AI
~1 spots leftby Mar 2025